Unilever (UL) · Consumer Brands
Unilever Q4 2025 earnings: summary, key numbers & outlook
Results filed 12 Feb 2026 · Quarter ended 31 Dec 2025
Press release ↗Investor relations ↗
Summaries and transcripts are machine-generated and can contain errors.
In brief
Unilever completed the Ice Cream demerger and used bolt-on deals like Dr. Squatch and Minimalist to tilt its portfolio toward Beauty, Wellbeing and Personal Care.
Unilever became a more focused company in 2025. It demerged Ice Cream in December, closed or announced 10 transactions, and bought Wild, Dr. Squatch and Minimalist while selling non-core brands, mainly in Foods. Growth was led by premium innovations such as Dove's fibre repair range, Whole Body Deodorants and Wonder Wash. Emerging markets sped up in the fourth quarter as resets in Indonesia and China took hold, while developed markets slowed.
Management wants more Beauty, Wellbeing and Personal Care, a push into premium segments and digital commerce, and growth anchored in the US and India, with a more category-led operating model. The tension is that markets are slowing: Unilever expects 2026 growth at the bottom of its 4% to 6% range, and the Indonesia rebound reflects de-stocking in the prior year that will not repeat.
No call transcript for this quarter, so this summary also draws on: RTÉ ↗, Cosmetics Business ↗, interactive investor ↗.
Key numbers
- Turnover (full year 2025) · GAAP
- €50.5 billion
- Operating profit (full year 2025) · GAAP
- €9.0 billion
- Underlying operating margin (full year 2025) · non-GAAP
- 20.0%
- Gross margin (full year 2025)
- 46.9%
- Diluted EPS (full year 2025) · GAAP
- €2.59
- Underlying EPS (full year 2025) · non-GAAP
- €3.08
- Free cash flow (full year 2025)
- €5.9 billion
down (3.8)% versus the prior year
up 2.4% versus 2024
up 60bps
up 20bps
up 6.2% versus the prior year
up 0.7%
down €0.4 billion
| Segment or metric | Value | Change |
|---|---|---|
| Beauty & Wellbeing | €12.8bn | underlying sales growth 4.3% |
| Personal Care | €13.2bn | underlying sales growth 4.7% |
| Home Care | €11.6bn | underlying sales growth 2.6% |
| Foods | €12.9bn | underlying sales growth 2.5% |
| Power Brands underlying sales growth | 4.3% | volume up 2.2% |
Where each number comes from
- Turnover (full year 2025): “Turnover €50.5 billion, down (3.8)%; with adverse currency (5.9)% and net disposals (1.2)%”
- Operating profit (full year 2025): “Operating profit was €9.0 billion, up 2.4% versus 2024, reflecting lower restructuring costs and a reduced loss on disposals compared to the prior year.”
- Underlying operating margin (full year 2025): “Underlying operating margin of 20.0% was up 60bps against a prior year base of 19.4%, driven by structural improvements in gross margin and overhead discipline”
- Gross margin (full year 2025): “Strong gross margin 46.9%, up 20bps, supporting brand & marketing investment up 10bps to 16.1%”
- Diluted EPS (full year 2025): “Diluted earnings per share of €2.59 increased by 6.2% versus the prior year.”
- Underlying EPS (full year 2025): “Underlying earnings per share increased 0.7% to €3.08, including (8.8)% of adverse currency.”
- Free cash flow (full year 2025): “100% cash conversion for the year, with free cash flow of €5.9 billion.”
- Beauty & Wellbeing: “Beauty & Wellbeing | €12.8bn | 4.3% | 2.2% | 2.1% | 19.2% | (20)bps | €3.2bn | 4.7%”
- Personal Care: “Personal Care | €13.2bn | 4.7% | 1.1% | 3.6% | 22.6% | 50bps | €3.3bn | 5.1%”
- Home Care: “Home Care | €11.6bn | 2.6% | 2.2% | 0.4% | 14.9% | 40bps | €2.8bn | 4.7%”
- Foods: “Foods | €12.9bn | 2.5% | 0.8% | 1.7% | 22.6% | 130bps | €3.3bn | 2.3%”
- Power Brands underlying sales growth: “Power Brands (78% of turnover) leading growth with 4.3% USG and volume up 2.2%”
Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.
Outlook
| Metric | Period | Outlook |
|---|---|---|
| Underlying sales growth | full year 2026 | 4% to 6% |
| Underlying volume growth | full year 2026 | at least 2% |
| Remaining productivity savings | 2026 | €130 million |
| New share buyback | from the second quarter of 2026 | up to €1.5 billion |
Key takeaways
Ice Cream demerger leaves a more focused Unilever
The demerger of The Magnum Ice Cream Company was completed on 6 December 2025, with Unilever keeping a stake of approximately 19.9% to be sold down in an orderly manner. This gives the group a clearer strategic and capital allocation focus.
Bolt-on deals push portfolio toward premium beauty and care
Unilever bought Wild, Dr. Squatch and Minimalist, and sold Conimex, The Vegetarian Butcher, Kate Somerville and Graze. It has completed or announced 10 transactions since the start of 2025, aiming at fewer, bigger and more scalable brands.
Premium innovation is driving Beauty & Wellbeing and Personal Care
Wellbeing, Vaseline and Dove grew double-digit, and Dove's fibre repair range and Whole Body Deodorants led the way. Oral Care brands Close Up and Pepsodent grew with premium whitening and naturals ranges.
Resets in Indonesia and China are improving emerging markets
Changes to route-to-market and portfolio in both markets led to a return to growth in the second half. Fourth-quarter emerging market volume grew 3.2%, though Indonesia also benefited from prior-year de-stocking that will not repeat.
Wonder Wash and Brazil fixes lift Home Care
Wonder Wash, launched in 2024, is now in 30 markets and supported strong European Home Care volume. Brazil returned to growth in the fourth quarter after pricing actions to restore competitiveness.
Questions
What is Unilever's strategic direction after the Ice Cream demerger?
Management wants more Beauty, Wellbeing and Personal Care, prioritising premium segments and digital commerce and anchoring growth in the US and India. It is also moving to a more category-led, execution-focused operating model.
Which acquisitions and disposals did Unilever make in 2025?
It acquired Wild, Dr. Squatch and Minimalist, and sold Conimex, The Vegetarian Butcher and Kate Somerville. In early 2026 it announced the sale of its Indonesia Tea business and its Home Care businesses in Colombia and Ecuador, and completed the sale of Graze.
Which products and brands drove growth?
Wellbeing (including Nutrafol and Liquid I.V.), Vaseline and Dove grew double-digit in Beauty & Wellbeing. Whole Body Deodorants, Wonder Wash, Comfort and Hellmann's flavoured mayonnaise also contributed.
How are emerging markets performing for Unilever?
Emerging markets accelerated in the fourth quarter, led by volume growth and the resets in Indonesia and China, plus a return to growth in Latin America. India gained share with 4% volume growth in the quarter.
What is the outlook for 2026?
Unilever expects underlying sales growth within its 4% to 6% multi-year range but at the bottom end because of slower markets, with at least 2% volume growth. It also expects a modest improvement in underlying operating margin versus 20.0% in 2025.
Documents
SEC filing